{
    "clinical_study": {
        "@rank": "10071", 
        "arm_group": [
            {
                "arm_group_label": "low energy diet", 
                "arm_group_type": "Experimental", 
                "description": "low energy diet treatment"
            }, 
            {
                "arm_group_label": "Nordic recommendation", 
                "arm_group_type": "Active Comparator", 
                "description": "Nordic recommendation, no restrictions on energy"
            }
        ], 
        "brief_summary": {
            "textblock": "30 obese moderate-to-severe heart failure patients will be randomized to intervention or\n      control in groups of 5-10 subjects.\n\n      All will receive dietetic advice according to randomization and according to the European\n      Heart Association.\n\n      Intervention subjects will initiate with 8 weeks low energy diet, 800-1000 kcal/d by formula\n      diet and subsequent four weeks reintroduction to regular foods supplying 1200 kcal/d\n      substituting two daily meals with formula meal replacement.\n\n      Control subjects are advised to follow the Nordic Nutrition Recommendations.\n\n      Patients will be monitored by blood sampling and assessed by change in physical performance."
        }, 
        "brief_title": "Weight Loss as Treatment in Heart Disease", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": [
                "Myocardial Ischemia", 
                "Heart Diseases", 
                "Heart Failure", 
                "Weight Loss"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  bmi >30\n\n          -  heart failure, moderate to severe, new york heart association II og III\n\n          -  stable disease\n\n          -  age >18 years\n\n          -  out-patients\n\n          -  perform a six minutes walk test\n\n          -  given consent\n\n        Exclusion Criteria:\n\n          -  unstable disease\n\n          -  insulin treated diabetes\n\n          -  pregnancy or lactating\n\n          -  unstable weight past 6 months (+- 10 kg)\n\n          -  planned procedures in the time of intervention"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02105805", 
            "org_study_id": "GEN-01-clinnutr"
        }, 
        "intervention": {
            "arm_group_label": [
                "low energy diet", 
                "Nordic recommendation"
            ], 
            "description": "Group sessions to improve dietary adherence", 
            "intervention_name": "Dietetic group sessions", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "intention weight loss", 
            "heart failure", 
            "6-minute walk test"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "number_of_arms": "2", 
        "official_title": "Intentional Weight Loss as Treatment in Obese Patients With Ischaemic Heart Disease", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: The Regional Committee on Biomedical Research Ethics", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Performance measure", 
            "measure": "Change in six minute walk test from baseline to week 16 (end of study)", 
            "safety_issue": "No", 
            "time_frame": "weeks 0 and 16"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02105805"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "Arne Astrup", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Blood sample and analyses for lipids", 
            "measure": "Change in lipid status from baseline to week 16 (end of study).", 
            "safety_issue": "No", 
            "time_frame": "weeks 0,1,2,4,6,8,10,12,14,16"
        }, 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "University Hospital, Gentofte, Copenhagen", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}